AVET PHARMACCEUTICALS INC., — Mycophenolate Importer Profile
Pharmaceutical Importer · #9 buyer for Mycophenolate · $1.4M import value · 29 shipments · UNITED STATES · DGFT Verified
AVET PHARMACCEUTICALS INC., is the #9 importer of Mycophenolate from India with $1.4M in import value and 29 verified shipments. AVET PHARMACCEUTICALS INC., holds a 0.4% market share in Mycophenolate imports based in UNITED STATES. The company sources from 1 verified supplier across 17 formulations shipped to 1 country. Overall, AVET PHARMACCEUTICALS INC., imports 5 pharmaceutical products worth $7.0M across 4 therapeutic categories.
AVET PHARMACCEUTICALS INC., — Mycophenolate Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Mycophenolate to AVET PHARMACCEUTICALS INC.,?
Verified from 29 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| STRIDES PHARMA SCIENCE LIMITED | $1.4M | 29 | 100.0% |
AVET PHARMACCEUTICALS INC., sources Mycophenolate from 1 verified Indian supplier based on 29 customs records. The primary supplier is STRIDES PHARMA SCIENCE LIMITED accounting for 100.0% of imports.
How Does AVET PHARMACCEUTICALS INC., Compare to Nearest Mycophenolate Importers?
Buyers ranked immediately above and below #9 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 15 | TILLOMED LABORATORIES LTD. | UNITED KINGDOM | $2.1M | 59 | $35.4K |
| 7 | SANDOZ INC C O EXEL INC | UNITED STATES | $1.9M | 38 | $50.0K |
| 9 | AVET PHARMACCEUTICALS INC., ★ | UNITED STATES | $1.4M | 29 | $50.0K |
| 12 | EVERSANA LIFE SCIENCES SERVICES LLC | UNITED STATES | $1.4M | 29 | $50.0K |
| 14 | ACCORD FARMACUTICA LTDA | BRAZIL | $950.0K | 19 | $50.0K |
AVET PHARMACCEUTICALS INC., ranks #9 among 512 Mycophenolate importers from India. Average shipment value of $50.0K compared to the market average of $79.1K. The closest competitors by value are TILLOMED LABORATORIES LTD. and SANDOZ INC C O EXEL INC.
Where Does AVET PHARMACCEUTICALS INC., Import Mycophenolate To?
Destination countries from 29 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.4M | 29 | 100.0% |
AVET PHARMACCEUTICALS INC., imports Mycophenolate to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $1.4M.
What Mycophenolate Formulations Does AVET PHARMACCEUTICALS INC., Import?
| Formulation | Value | Shipments |
|---|---|---|
| MYCOPHENOLATE MOFETIL TABLETS USP 500MG | $200.0K | 4 |
| MYCOPHENOLATE MOFETIL TABLETS USP [500MG] [FC] [US] - ANDA NO : 90456 NDC NO : 23155-836-01. | $200.0K | 4 |
| MYCOPHENOLATE MOFETIL TABLETS USP 500MG FC US EACH FILM COATED TABLET CONTAINS MYCOPHENOLATE MOFETIL USP 500MG. | $150.0K | 3 |
| MYCOPHENOLATE MOFETIL TABLETS USP500MG | $100.0K | 2 |
| MYCOPHENOLATE MOFETIL TABLETS USP 500MG FC US EACH FILM COATED TABLET CONTAINS MYCOPHENOLATE MOFETIL USP 500MG | $100.0K | 2 |
| MYCOPHENOLATE MOFETIL TABLETS USP [500MG] [FC] [US] - ANDA NO: 090456 NDC NO: 23155-836-05 | $100.0K | 2 |
| MYCOPHENOLATE MOFETIL CAPSULES USP250MG | $89.4K | 2 |
| MYCOPHENOLATE MOFETIL TABLETS USP 500MG FC US 3,876.000 PAC X 500S EACH FILM COATED TABLET CONTAINS MYCOPHENOLATENOS | $50.0K | 1 |
| MYCOPHENOLATE MOFETIL TABLETS USP 500MG FC US EACH FILM COATED TABLET CONTAINS MYCOPHENOLATE MOFETIL USP 500MGNOS | $50.0K | 1 |
| MYCOPHENOLATE MOFETIL TABLETS USP 500MG FC US EACH FILM COATED TABLET CONTAINS MYCOPHENOLATE MOFETIL USP 500MG 9,7 | $50.0K | 1 |
AVET PHARMACCEUTICALS INC., imports 17 distinct Mycophenolate formulations from India. The top formulation is MYCOPHENOLATE MOFETIL TABLETS USP 500MG with 4 shipments worth $200.0K.
Regulatory Requirements: Importing Mycophenolate into United States
What AVET PHARMACCEUTICALS INC., and other importers must comply with to import Mycophenolate from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Mycophenolate
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Mycophenolate from India and How Much Does AVET PHARMACCEUTICALS INC., Import?
India exported $40.5M worth of Mycophenolate through 2,529 shipments from 167 suppliers to 100 countries, serving 512 buyers globally. AVET PHARMACCEUTICALS INC., imports $1.4M of this total, accounting for 0.4% of India's Mycophenolate exports with 29 shipments from UNITED STATES. This is verified from 29 customs shipment records covering 17 distinct formulations.
What Is the Average Order Value for AVET PHARMACCEUTICALS INC.,'s Mycophenolate Imports?
AVET PHARMACCEUTICALS INC.,'s average Mycophenolate order value is $47.1K per consignment, based on 29 shipments totaling $1.4M. AVET PHARMACCEUTICALS INC., is based in UNITED STATES and ranks #9 among all Mycophenolate importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Mycophenolate to AVET PHARMACCEUTICALS INC.,?
AVET PHARMACCEUTICALS INC., sources Mycophenolate from 1 verified Indian supplier: STRIDES PHARMA SCIENCE LIMITED ($1.4M, 100.0%). This is based on 29 customs records.
How Does AVET PHARMACCEUTICALS INC., Compare to Other Mycophenolate Importers?
AVET PHARMACCEUTICALS INC., ranks #9 among 512 Mycophenolate importers from India with a 0.4% market share. The top 3 importers are ASCEND LABORATORIES,LLC ($6.5M), EVERSANA LIFE SCIENCES SERVICES,LLC ($4.9M), STRIDES PHARMA INC ($3.6M). AVET PHARMACCEUTICALS INC., processed 29 shipments from UNITED STATES.
What Other Immunosuppressants Products Does AVET PHARMACCEUTICALS INC., Import?
AVET PHARMACCEUTICALS INC., also imports these immunosuppressants products. Each links to the detailed product page.
About AVET PHARMACCEUTICALS INC.,
AVET PHARMACCEUTICALS INC., imports 5 products worth $7.0M. Beyond Mycophenolate, top products include Cyclosporine, Nystatin, Vancomycin, Colchicine. View the complete AVET PHARMACCEUTICALS INC., profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Mycophenolate — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Mycophenolate shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: AVET PHARMACCEUTICALS INC., matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as AVET PHARMACCEUTICALS INC.,'s capped import value divided by total capped export value for Mycophenolate across all Indian exporters.
- 5.Verified Records: This page is backed by 29 individual customs records matching AVET PHARMACCEUTICALS INC., importing Mycophenolate, covering 17 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 100+ countries, 512+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Mycophenolate Import Data for AVET PHARMACCEUTICALS INC.,
Access order-level details, pricing data, supplier connections, and competitive analysis for AVET PHARMACCEUTICALS INC.,'s Mycophenolate imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
AVET PHARMACCEUTICALS INC.,
Full Company Profile →
5 products · $7.0M total trade · 4 categories
AVET PHARMACCEUTICALS INC., × Mycophenolate
Verified from customs records
Company Overview
Top Products by AVET PHARMACCEUTICALS INC.,
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for AVET PHARMACCEUTICALS INC.,.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Mycophenolate. For current order-level data, contact TransData Nexus.